News & Analysis on Clinical Trial Services & Contract Research And Development
Micap, a UK company specialising in using yeast cells to encapsulate drugs, has entered into a collaboration with leading medicated chewing gum company Fertin that should extend the range of active ingredients that can be delivered via this route.
NovAseptic has launched what it claims is the first high shear mixer that uses a magnet-driven mechanism, designed to make it easier to clean and reduce the risk of contamination.
A new drug delivery company, Merrion Pharmaceuticals, has been set up to commercialise various technologies originally developed at Ireland's Elan, which sold off many of its assets after growing too quickly throughout the 1990s.
Germany's MWG Biotech has launched its own line of small interfering RNA (siRNA) reagents, siMAX, encroaching into territory dominated by the likes of Qiagen, Dharmacon, Ambion, Proligo and Invitrogen.
Researchers at Harvard have discovered why cholesterol-lowering drugs do not have identical effects on patients. These medicines on average cut heart attacks by a third and with sales of $26 billion dollars and used by 20 million people,...
A proposal requiring drug companies to register clinical trials in a public database to be considered for later publication - regardless of results - is being considered by top medical journals, writes Wai Lang Chu.